News coverage about Align Technology (NASDAQ:ALGN) has trended somewhat positive this week, according to Accern. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Align Technology earned a news impact score of 0.22 on Accern’s scale. Accern also assigned media stories about the medical equipment provider an impact score of 45.6430520320573 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

Shares of Align Technology (NASDAQ ALGN) traded down $1.03 during midday trading on Monday, hitting $253.89. 666,700 shares of the stock traded hands, compared to its average volume of 1,006,345. Align Technology has a one year low of $88.56 and a one year high of $257.60. The stock has a market cap of $20,490.00, a PE ratio of 75.11, a PEG ratio of 2.43 and a beta of 1.41.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.82 by $0.19. Align Technology had a net margin of 19.98% and a return on equity of 25.60%. The company had revenue of $385.30 million during the quarter, compared to analysts’ expectations of $359.80 million. During the same period in the previous year, the company earned $0.63 EPS. The business’s quarterly revenue was up 38.3% compared to the same quarter last year. analysts predict that Align Technology will post 3.62 earnings per share for the current year.

A number of research analysts have recently weighed in on ALGN shares. Stifel Nicolaus raised their price objective on shares of Align Technology from $205.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, October 23rd. Robert W. Baird set a $208.00 price objective on shares of Align Technology and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Northcoast Research reissued a “buy” rating and set a $230.00 price objective (up from $200.00) on shares of Align Technology in a research note on Tuesday, October 10th. Piper Jaffray Companies reissued a “buy” rating and set a $176.00 price objective on shares of Align Technology in a research note on Friday, July 28th. Finally, Bank of America Corporation raised shares of Align Technology from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $175.00 to $193.00 in a research note on Friday, July 28th. Eleven analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and an average target price of $219.18.

ILLEGAL ACTIVITY WARNING: This story was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at https://www.dailypolitical.com/2017/11/20/align-technology-algn-getting-somewhat-positive-press-coverage-analysis-shows.html.

In related news, VP Julie Tay sold 3,500 shares of Align Technology stock in a transaction on Monday, November 13th. The shares were sold at an average price of $253.00, for a total transaction of $885,500.00. Following the transaction, the vice president now owns 12,213 shares in the company, valued at approximately $3,089,889. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Greg J. Santora sold 7,700 shares of Align Technology stock in a transaction on Tuesday, October 31st. The shares were sold at an average price of $238.95, for a total transaction of $1,839,915.00. The disclosure for this sale can be found here. Insiders have sold a total of 16,600 shares of company stock valued at $4,031,567 over the last three months. Corporate insiders own 1.60% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.